Senestech Inc's Corporate Customers have recorded an advance in their cost of revenue by 0.5 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 10.65 %. During the corresponding time, Senestech Inc recorded a revenue increase by 23.2 % year on year, sequentially revenue grew by 56.19 %. While revenue at the Senestech Inc 's corporate clients recorded rose by 1.19 % year on year, sequentially revenue grew by 17.65 %.
Senestech Inc's Customers have recorded an advance in their cost of revenue by 0.5 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 10.65 %, for the same period Senestech Inc recorded revenue increase by 23.2 % year on year, sequentially revenue grew by 56.19 %.
Senestech Inc's Comment on Sales, Marketing and Customers
The company serves the pest control industry, focusing on obtaining regulatory approvals to expand the use and marketability of its products primarily in the United States and potentially internationally. Its market includes pest control programs targeting rodent populations, specifically rats and mice, which reproduce rapidly and may develop resistance to traditional lethal control methods such as traps and rodenticides. Challenges faced by customers include rodent behaviors that reduce bait effectiveness and genetic resistance to anticoagulant rodenticides. The company offers fertility control products as a non-lethal alternative that is not affected by such resistance.
Senestech Inc’s Comment on Sales, Marketing and Customers
The company serves the pest control industry, focusing on obtaining regulatory approvals to expand the use and marketability of its products primarily in the United States and potentially internationally. Its market includes pest control programs targeting rodent populations, specifically rats and mice, which reproduce rapidly and may develop resistance to traditional lethal control methods such as traps and rodenticides. Challenges faced by customers include rodent behaviors that reduce bait effectiveness and genetic resistance to anticoagulant rodenticides. The company offers fertility control products as a non-lethal alternative that is not affected by such resistance.
Sources:
Senestech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Senestech Inc’s corporate clients.
For your research, we’ve provided 9 tables on Senestech Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
16.18 %